Global Secondary Progressive Multiple Sclerosis Drug Market Data Survey Report 2015-2025
- HEY3507288
- 76 Pages
- February 2020
- Healthcare
The global Secondary Progressive Multiple Sclerosis Drug market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major End-Use
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
AB Science SA
Actelion Ltd
Biogen, Inc.
F. Hoffmann-La Roche Ltd.
Genzyme Corporation
Glialogix, Inc.
Immune Response BioPharma, Inc.
Innate Immunotherapeutics Ltd
Kyorin Pharmaceutical Co., Ltd.
Mallinckrodt Plc
MedDay SA
MedImmune, LLC
Merck KGaA
Meta-IQ ApS
Novartis AG
Opexa Therapeutics, Inc.
Xenetic Biosciences (UK) Limited
Major applications as follows:
Hospital
Clinic
Others
Major Type as follows:
Inebilizumab
GLX-1112
DC-TAB
Etomoxir
IB-MS
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of End-Use
1.1.4 Scope of Product Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
Fig Global Secondary Progressive Multiple Sclerosis Drug Market Size and CAGR 2015-2019 (Million USD)
Fig Global Secondary Progressive Multiple Sclerosis Drug Market Size and CAGR 2015-2019 (Volume)
Fig Global Secondary Progressive Multiple Sclerosis Drug Market Forecast and CAGR 2020-2025 (Million USD)
Fig Global Secondary Progressive Multiple Sclerosis Drug Market Forecast and CAGR 2020-2025 (Volume)
2 Regional Market
2.1 Regional Sales
Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
2.2 Regional Demand
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
2.3 Regional Trade
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)
3 Key Manufacturers
3.1 AB Science SA
3.1.1 Company Information
Tab Company Profile List of AB Science SA
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of AB Science SA
3.1.4 Recent Development
3.2 Actelion Ltd
3.2.1 Company Information
Tab Company Profile List of Actelion Ltd
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Actelion Ltd
3.2.4 Recent Development
3.3 Biogen, Inc.
3.3.1 Company Information
Tab Company Profile List of Biogen, Inc.
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Biogen, Inc.
3.3.4 Recent Development
3.4 F. Hoffmann-La Roche Ltd.
3.4.1 Company Information
Tab Company Profile List of F. Hoffmann-La Roche Ltd.
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd.
3.4.4 Recent Development
3.5 Genzyme Corporation
3.5.1 Company Information
Tab Company Profile List of Genzyme Corporation
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Genzyme Corporation
3.5.4 Recent Development
3.6 Glialogix, Inc.
3.6.1 Company Information
Tab Company Profile List of Glialogix, Inc.
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Glialogix, Inc.
3.6.4 Recent Development
3.7 Immune Response BioPharma, Inc.
3.7.1 Company Information
Tab Company Profile List of Immune Response BioPharma, Inc.
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Immune Response BioPharma, Inc.
3.7.4 Recent Development
3.8 Innate Immunotherapeutics Ltd
3.8.1 Company Information
Tab Company Profile List of Innate Immunotherapeutics Ltd
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Innate Immunotherapeutics Ltd
3.8.4 Recent Development
3.9 Kyorin Pharmaceutical Co., Ltd.
3.9.1 Company Information
Tab Company Profile List of Kyorin Pharmaceutical Co., Ltd.
3.9.2 Product & Services
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Kyorin Pharmaceutical Co., Ltd.
3.9.4 Recent Development
3.10 Mallinckrodt Plc
3.10.1 Company Information
Tab Company Profile List of Mallinckrodt Plc
3.10.2 Product & Services
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Mallinckrodt Plc
3.10.4 Recent Development
3.11 MedDay SA
3.11.1 Company Information
Tab Company Profile List of MedDay SA
3.11.2 Product & Services
3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of MedDay SA
3.11.4 Recent Development
3.12 MedImmune, LLC
3.12.1 Company Information
Tab Company Profile List of MedImmune, LLC
3.12.2 Product & Services
3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of MedImmune, LLC
3.12.4 Recent Development
3.13 Merck KGaA
3.13.1 Company Information
Tab Company Profile List of Merck KGaA
3.13.2 Product & Services
3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Merck KGaA
3.13.4 Recent Development
3.14 Meta-IQ ApS
3.14.1 Company Information
Tab Company Profile List of Meta-IQ ApS
3.14.2 Product & Services
3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Meta-IQ ApS
3.14.4 Recent Development
3.15 Novartis AG
3.15.1 Company Information
Tab Company Profile List of Novartis AG
3.15.2 Product & Services
3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Novartis AG
3.15.4 Recent Development
3.16 Opexa Therapeutics, Inc.
3.16.1 Company Information
Tab Company Profile List of Opexa Therapeutics, Inc.
3.16.2 Product & Services
3.16.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Opexa Therapeutics, Inc.
3.17 Xenetic Biosciences (UK) Limited
3.17.1 Company Information
Tab Company Profile List of Xenetic Biosciences (UK) Limited
3.17.2 Product & Services
3.17.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Xenetic Biosciences (UK) Limited
4 Major End-Use
4.1 Hospital
4.1.1 Overview
Tab Summary of Consumption Distribution of Hospital
4.1.2 Hospital Market Size and Forecast
Fig Hospital Market Size and CAGR 2015-2019 (Million USD)
Fig Hospital Market Size and CAGR 2015-2019 (Volume)
Fig Hospital Market Forecast and CAGR 2020-2025 (Million USD)
Fig Hospital Market Forecast and CAGR 2020-2025 (Volume)
4.2 Clinic
4.2.1 Overview
Tab Summary of Consumption Distribution of Clinic
4.2.2 Clinic Market Size and Forecast
Fig Clinic Market Size and CAGR 2015-2019 (Million USD)
Fig Clinic Market Size and CAGR 2015-2019 (Volume)
Fig Clinic Market Forecast and CAGR 2020-2025 (Million USD)
Fig Clinic Market Forecast and CAGR 2020-2025 (Volume)
4.3 Others
4.3.1 Overview
Tab Summary of Consumption Distribution of Others
4.3.2 Others Market Size and Forecast
Fig Others Market Size and CAGR 2015-2019 (Million USD)
Fig Others Market Size and CAGR 2015-2019 (Volume)
Fig Others Market Forecast and CAGR 2020-2025 (Million USD)
Fig Others Market Forecast and CAGR 2020-2025 (Volume)
5 Market by Type
5.1 Inebilizumab
5.1.1 Overview
Tab Product Overview of Inebilizumab
5.1.2 Inebilizumab Market Size and Forecast
Fig Inebilizumab Market Size and CAGR 2015-2019 (Million USD)
Fig Inebilizumab Market Size and CAGR 2015-2019 (Volume)
Fig Inebilizumab Market Forecast and CAGR 2020-2025 (Million USD)
Fig Inebilizumab Market Forecast and CAGR 2020-2025 (Volume)
5.2 GLX-1112
5.2.1 Overview
Tab Product Overview of GLX-1112
5.2.2 GLX-1112 Market Size and Forecast
Fig GLX-1112 Market Size and CAGR 2015-2019 (Million USD)
Fig GLX-1112 Market Size and CAGR 2015-2019 (Volume)
Fig GLX-1112 Market Forecast and CAGR 2020-2025 (Million USD)
Fig GLX-1112 Market Forecast and CAGR 2020-2025 (Volume)
5.3 DC-TAB
5.3.1 Overview
Tab Product Overview of DC-TAB
5.3.2 DC-TAB Market Size and Forecast
Fig DC-TAB Market Size and CAGR 2015-2019 (Million USD)
Fig DC-TAB Market Size and CAGR 2015-2019 (Volume)
Fig DC-TAB Market Forecast and CAGR 2020-2025 (Million USD)
Fig DC-TAB Market Forecast and CAGR 2020-2025 (Volume)
5.4 Etomoxir
5.4.1 Overview
Tab Product Overview of Etomoxir
5.4.2 Etomoxir Market Size and Forecast
Fig Etomoxir Market Size and CAGR 2015-2019 (Million USD)
Fig Etomoxir Market Size and CAGR 2015-2019 (Volume)
Fig Etomoxir Market Forecast and CAGR 2020-2025 (Million USD)
Fig Etomoxir Market Forecast and CAGR 2020-2025 (Volume)
5.5 IB-MS
5.5.1 Overview
Tab Product Overview of IB-MS
5.5.2 IB-MS Market Size and Forecast
Fig IB-MS Market Size and CAGR 2015-2019 (Million USD)
Fig IB-MS Market Size and CAGR 2015-2019 (Volume)
Fig IB-MS Market Forecast and CAGR 2020-2025 (Million USD)
Fig IB-MS Market Forecast and CAGR 2020-2025 (Volume)
5.6 Others
5.6.1 Overview
Tab Product Overview of Others
5.6.2 Others Market Size and Forecast
Fig Others Market Size and CAGR 2015-2019 (Million USD)
Fig Others Market Size and CAGR 2015-2019 (Volume)
Fig Others Market Forecast and CAGR 2020-2025 (Million USD)
Fig Others Market Forecast and CAGR 2020-2025 (Volume)
6 Price Overview
6.1 Price by Manufacturers
Tab Different Products Prices List of Major Manufacturers
6.2 Price by End-Use
Tab Different Products Prices List of End-Use
6.3 Price by Type
Tab Different Products Prices List of Produt Type
7 Conclusion
Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)
Tab Company Profile List of AB Science SA
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of AB Science SA
Tab Company Profile List of Actelion Ltd
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Actelion Ltd
Tab Company Profile List of Biogen, Inc.
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Biogen, Inc.
Tab Company Profile List of F. Hoffmann-La Roche Ltd.
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd.
Tab Company Profile List of Genzyme Corporation
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Genzyme Corporation
Tab Company Profile List of Glialogix, Inc.
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Glialogix, Inc.
Tab Company Profile List of Immune Response BioPharma, Inc.
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Immune Response BioPharma, Inc.
Tab Company Profile List of Innate Immunotherapeutics Ltd
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Innate Immunotherapeutics Ltd
Tab Company Profile List of Kyorin Pharmaceutical Co., Ltd.
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Kyorin Pharmaceutical Co., Ltd.
Tab Company Profile List of Mallinckrodt Plc
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Mallinckrodt Plc
Tab Company Profile List of MedDay SA
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of MedDay SA
Tab Company Profile List of MedImmune, LLC
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of MedImmune, LLC
Tab Company Profile List of Merck KGaA
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Merck KGaA
Tab Company Profile List of Meta-IQ ApS
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Meta-IQ ApS
Tab Company Profile List of Novartis AG
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Novartis AG
Tab Company Profile List of Opexa Therapeutics, Inc.
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Opexa Therapeutics, Inc.
Tab Company Profile List of Xenetic Biosciences (UK) Limited
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Xenetic Biosciences (UK) Limited
Tab Summary of Consumption Distribution of Hospital
Tab Summary of Consumption Distribution of Clinic
Tab Summary of Consumption Distribution of Others
Tab Product Overview of Inebilizumab
Tab Product Overview of GLX-1112
Tab Product Overview of DC-TAB
Tab Product Overview of Etomoxir
Tab Product Overview of IB-MS
Tab Product Overview of Others
Tab Different Products Prices List of Major Manufacturers
Tab Different Products Prices List of End-Use
Tab Different Products Prices List of Produt Type
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
